Evidence map›Paper›PMID 40376688›Full record

ArticleChina CDC weekly2025

The First Imported Case of Lassa Fever - China, 2024.

Yao Wang, Xianying Wen, Dan Li, Shuangfeng Fan, Xingyu Zhou, Ke Yan, Jie Cao, Jiandong Li, Rongjie Wei, Hui Liu and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yao Wang *Chengdu Center for Disease Control and Prevention, Chengdu City, Sichuan Province, China.
Xianying Wen *Mianyang Center for Disease Control and Prevention, Mianyang City, Sichuan Province, China.
Dan Li *National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.
Shuangfeng FanChengdu Center for Disease Control and Prevention, Chengdu City, Sichuan Province, China.
Xingyu ZhouSichuan Provincial Center for Disease Control and Prevention, Chengdu City, Sichuan Province, China.
Ke YanChengdu Center for Disease Control and Prevention, Chengdu City, Sichuan Province, China.
Jie CaoJiangyou Center for Disease Control and Prevention, Mianyang City, Sichuan Province, China.
Jiandong LiNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Biosafety, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Rongjie WeiSichuan Provincial Center for Disease Control and Prevention, Chengdu City, Sichuan Province, China.
Hui LiuChengdu Center for Disease Control and Prevention, Chengdu City, Sichuan Province, China.
Wei WuNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Senping ZhengWuhou District Centre for Disease Control and Prevention, Chengdu City, Sichuan Province, China.
Rongmeng JiangBeijing Ditan Hospital, Capital Medical University, Beijing, China.
Yun PengChengdu Center for Disease Control and Prevention, Chengdu City, Sichuan Province, China.
Yuliang FengSichuan Provincial Center for Disease Control and Prevention, Chengdu City, Sichuan Province, China.
Nijuan XiangNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing, China.
Jiushun ZhouSichuan Provincial Center for Disease Control and Prevention, Chengdu City, Sichuan Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: Lassa fever, an acute viral hemorrhagic illness caused by Lassa virus, is primarily transmitted through contact with rodents, particularly What is added by this report?: The clinical manifestations of Lassa fever (LF) are nonspecific and may closely resemble those of other febrile illnesses, posing challenges for detection at points of entry and during medical evaluations. In this severe case, the patient experienced coma and developed persistent hearing loss even after discharge, emphasizing the critical importance of early diagnosis and treatment. What are the implications for public health practice?: For cases with unclear diagnoses, healthcare providers should prioritize obtaining a detailed 30-day travel history to assess the potential risk of imported infectious diseases. Public health strategies in Africa must prioritize: 1) community-tailored health education campaigns, 2) enhanced syndromic surveillance coupled with pathogen-specific research, and 3) sustainable stockpiling of rapid diagnostic tests (RDTs) for endemic infections alongside accelerated vaccine development pipelines.

Indexed as

imported casesLassa feverpublic health emergency

Identifiers

PMID40376688
PMCPMC12075435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.